XIAOMING JIA to Disease Progression
This is a "connection" page, showing publications XIAOMING JIA has written about Disease Progression.
Connection Strength
0.064
-
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials. EBioMedicine. 2023 Jul; 93:104662.
Score: 0.032
-
Multi-arm U-Net with dense input and skip connectivity for T2 lesion segmentation in clinical trials of multiple sclerosis. Sci Rep. 2023 03 13; 13(1):4102.
Score: 0.032